Emicizumab inj. 30mg 1.0ml
Indian Council of Medical Research · Mumbai · Pharmaceuticals · open
Key facts
- Closing date: 01 Sep 2026
- Status: open
- Ministry: Ministry of Health and Family Welfare
- Department: Department of Health Research
- Office: Mumbai
Description
Tender for supply of Emicizumab injections in multiple categories, with a quantity of 15 units, issued by the Indian Council of Medical Research under the Department of Health Research, Ministry of Health and Family Welfare. Bid validity is 180 days from the end date, with bid opening scheduled for 01-09-2026 at 09:30 AM.
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: No
- Documents required: Udyam Certificate, OEM Authorization Certificate, BoQ compliance documents
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: item wise evaluation
- Make in India (MII): No
- MSE preference: Yes
Line items (1)
- Emicizumab inj. 30mg 1.0ml A — Qty: 15 unit
1 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Running Contract for Tab/Cap Azelnidipine 16 mg in strip packing. — Pharmaceuticals
- Running Contract for Sodium Chloride 3%, 100 ml Glass Bottle. — Pharmaceuticals
- Running Contract for Salbutamol 2.5 mg /2.5 ml Nebulising Solution 2.5 ml Respule/Amp. — Pharmaceuticals